| Karri Bowen, | |
|
17275 124th St Se, Becker, MN 55308-4636 | |
| (614) 205-4610 | |
| Not Available |
| Full Name | Karri Bowen |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 17275 124th St Se, Becker, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396375994 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 2341738 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karri Bowen, 17275 124th St Se, Becker, MN 55308-4636 Ph: (614) 205-4610 | Karri Bowen, 17275 124th St Se, Becker, MN 55308-4636 Ph: (614) 205-4610 |
News Archive
Women who do not receive enough vitamin D during pregnancy and lactation can experience serious health problems for themselves and their baby, but health experts offer conflicting advice on what constitutes a safe amount.
Disease activity in patients with rheumatoid arthritis (RA) is significantly reduced during pregnancy, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
Women who stop taking antidepressant medications during pregnancy are at a five times greater risk for recurrence of depression than are women who continue taking their medication throughout their pregnancies, according to a multi-institutional study published in the Journal of the American Medical Association.
Quintiles today announced a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development. Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
› Verified 5 days ago
Carmen Huhn, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10333 165th Ave Se, Becker, MN 55308 Phone: 320-469-3034 |